The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly this year in the obesity drug space.
This is the feed from
CNBC - Healthcare
Is this your feed? Claim it!
Publisher: Unclaimed!
Message frequency: 5.25 / week
Message History
China is becoming a leader in biotech innovation. That offers hope to rare disease patients and presents a problem to American companies trying to save them.
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.
Torch CEO Ilya Abyzov previously co-founded Forward, a direct-to-consumer primary care business that did patient visits with tech-enabled "CarePods."
Thank you for your support of CNBC Cures. To share your story or become involved with CNBC Cures, email us at [email protected].
